TEST Campaign Landing Page

Dr. Ryan Manno: Welcome to Live Well with UCI Health. I'm Ryan Manno. Today we're joined by Dr. David Lee, a board-certified urologist specializing in prostate cancer treatment at UCI Health. Dr. David Lee: Thank you for having me, Ryan. It's great to be here to discuss our comprehensive prostate cancer program. Dr. Ryan Manno: Dr. Lee, can you tell us about the latest advances in prostate cancer detection and treatment? Dr. David Lee: Absolutely. One of the most significant advances has been in imaging technology. We now have MRI fusion biopsy technology that allows us to detect cancers earlier and with greater precision than ever before. We've also made tremendous strides in treatment options. For patients who need surgery, robotic-assisted procedures offer faster recovery times and better outcomes. For others, we have advanced radiation therapy options including stereotactic body radiation therapy. Dr. Ryan Manno: That's fascinating. What about patients who are diagnosed with early-stage prostate cancer? Dr. David Lee: For many patients with low-risk prostate cancer, active surveillance is actually the best option. We monitor the cancer closely with regular PSA tests, physical exams, and periodic biopsies. This allows patients to avoid the potential side effects of treatment until and unless treatment becomes necessary. Dr. Ryan Manno: What should men know about prostate cancer screening? Dr. David Lee: Screening should be a shared decision between a man and his doctor. Generally, we recommend men begin discussing screening at age 50, or earlier if they have risk factors such as family history or African American ancestry. The key is early detection. When caught early, prostate cancer is highly treatable, with cure rates exceeding 90%. Dr. Ryan Manno: Dr. Lee, thank you so much for sharing your expertise with us today. Dr. David Lee: My pleasure, Ryan. Thank you for having me.